Publications by authors named "Per S Holm"

12Publications

Irradiation enhances the therapeutic effect of the oncolytic adenovirus XVir-N-31 in brain tumor initiating cells.

Authors:
Rebecca Czolk Niklas Schwarz Henner Koch Sonja Schötterl Thomas V Wuttke Per S Holm Stephan M Huber Ulrike Naumann

Int J Mol Med 2019 Oct 31;44(4):1484-1494. Epub 2019 Jul 31.

Department of Vascular Neurology, Laboratory for Molecular Neuro‑Oncology, Hertie Institute for Clinical Brain Research, Tübingen NeuroCampus, University of Tübingen, D‑72076 Tübingen, Germany.

View Article and Find Full Text PDF
October 2019

Moving oncolytic viruses into the clinic: clinical-grade production, purification, and characterization of diverse oncolytic viruses.

Authors:
Guy Ungerechts Sascha Bossow Barbara Leuchs Per S Holm Jean Rommelaere Matt Coffey Rob Coffin John Bell Dirk M Nettelbeck

Mol Ther Methods Clin Dev 2016 6;3:16018. Epub 2016 Apr 6.

German Cancer Research Center (DKFZ) , Heidelberg, Germany.

View Article and Find Full Text PDF
April 2016

CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1.

Authors:
Anuja Sathe Nicole Koshy Sebastian C Schmid Mark Thalgott Sarah M Schwarzenböck Bernd J Krause Per S Holm Juergen E Gschwend Margitta Retz Roman Nawroth

J Urol 2016 Mar 28;195(3):771-9. Epub 2015 Aug 28.

Department of Urology, Klinikum rechts der Isar, Technische Universität München, Munich, Germany; Department of Nuclear Medicine, Rostock University Medical Centre (SMS, BJK), Rostock, Germany. Electronic address:

View Article and Find Full Text PDF
March 2016

EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS Gene.

Authors:
Geoffrey K Grünwald Alexandra Vetter Kathrin Klutz Michael J Willhauck Nathalie Schwenk Reingard Senekowitsch-Schmidtke Markus Schwaiger Christian Zach Ernst Wagner Burkhard Göke Per S Holm Manfred Ogris Christine Spitzweg

Mol Ther Nucleic Acids 2013 Nov 5;2:e131. Epub 2013 Nov 5.

Department of Internal Medicine II - Campus Grosshadern, University Hospital of Munich, Munich, Germany.

View Article and Find Full Text PDF
November 2013

Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.

Authors:
Geoffrey K Grünwald Alexandra Vetter Kathrin Klutz Michael J Willhauck Nathalie Schwenk Reingard Senekowitsch-Schmidtke Markus Schwaiger Christian Zach Ernst Wagner Burkhard Göke Per S Holm Manfred Ogris Christine Spitzweg

J Nucl Med 2013 Aug 10;54(8):1450-7. Epub 2013 Jul 10.

Department of Internal Medicine II-Campus Grosshadern, University Hospital of Munich, Munich, Germany.

View Article and Find Full Text PDF
August 2013

Adenoviral vectors coated with PAMAM dendrimer conjugates allow CAR independent virus uptake and targeting to the EGF receptor.

Authors:
Alexandra Vetter Kulpreet S Virdi Sigrid Espenlaub Wolfgang Rödl Ernst Wagner Per S Holm Christina Scheu Florian Kreppel Christine Spitzweg Manfred Ogris

Mol Pharm 2013 Feb 18;10(2):606-18. Epub 2013 Jan 18.

Center for System Based Drug Research, Department of Pharmacy, LMU Munich, Germany.

View Article and Find Full Text PDF
February 2013

Elevated YB-1 expression is a new unfavorable prognostic factor in non-Hodgkin's lymphomas.

Authors:
Katarzyna Szczuraszek Agnieszka Halon Verena Materna Grzegorz Mazur Tomasz Wrobel Kazimierz Kuliczkowski Piotr Donizy Per S Holm Hermann Lage Pawel Surowiak

Anticancer Res 2011 Sep;31(9):2963-70

Department of Histology and Embryology, Wroclaw Medical University, Wroclaw, Poland.

View Article and Find Full Text PDF
September 2011

YB-1 dependent virotherapy in combination with temozolomide as a multimodal therapy approach to eradicate malignant glioma.

Authors:
Regina Holzmüller Klaus Mantwill Cornelia Haczek Emanuel Rognoni Martina Anton Atsuko Kasajima Wilko Weichert Denise Treue Hermann Lage Tibor Schuster Jürgen Schlegel Bernd Gänsbacher Per S Holm

Int J Cancer 2011 Sep 6;129(5):1265-76. Epub 2011 Jan 6.

Institut für Experimentelle Onkologie und Therapieforschung, Klinikum Rechts der Isar, Munich, Germany.

View Article and Find Full Text PDF
September 2011

Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents.

Authors:
Klaus Mantwill Nadia Köhler-Vargas Alexandra Bernshausen Alexa Bieler Hermann Lage Alexander Kaszubiak Pavel Surowiak Tanja Dravits Uwe Treiber Rudolf Hartung Bernd Gansbacher Per S Holm

Cancer Res 2006 Jul;66(14):7195-202

Institute of Experimental Oncology and Department of Urology, Technical University of Munich, Klinikum rechts der Isar, Germany.

View Article and Find Full Text PDF
July 2006

Novel three-pronged strategy to enhance cancer cell killing in glioblastoma cell lines: histone deacetylase inhibitor, chemotherapy, and oncolytic adenovirus dl520.

Authors:
Alexa Bieler Klaus Mantwill Tanja Dravits Alexandra Bernshausen Gabriel Glockzin Nadia Köhler-Vargas Hermann Lage Bernd Gansbacher Per S Holm

Hum Gene Ther 2006 Jan;17(1):55-70

Institute of Experimental Oncology, Technical University of Munich, Klinikum Rechts-der-Isar, 81675 Munich, Germany.

View Article and Find Full Text PDF
January 2006

Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy.

Authors:
Per S Holm Hermann Lage Stephan Bergmann Karsten Jürchott Gabriel Glockzin Alexandra Bernshausen Klaus Mantwill Axel Ladhoff Anke Wichert Joe S Mymryk Thomas Ritter Manfred Dietel Bernd Gänsbacher Hans-Dieter Royer

Cancer Res 2004 Jan;64(1):322-8

Institut für Experimentelle Onkologie und Therapieforschung, Technische Universität München, Klinikum Rechts der Isar, München, Germany.

View Article and Find Full Text PDF
January 2004

YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter.

Authors:
Per S Holm Stephan Bergmann Karsten Jurchott Hermann Lage Karsten Brand Axel Ladhoff Klaus Mantwill David T Curiel Matthias Dobbelstein Manfred Dietel Bernd Gansbacher Hans-Dieter Royer

J Biol Chem 2002 Mar 11;277(12):10427-34. Epub 2002 Jan 11.

Institut für Experimentelle Onkologie und Therapieforschung, Technische Universität München, Klinikum Rechts der Isar, München 81675, Germany.

View Article and Find Full Text PDF
March 2002